{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:29:18Z","timestamp":1794493758920,"version":"4.9.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7734","license":[{"start":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T00:00:00Z","timestamp":1543363200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1038\/s41586-018-0756-0","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T15:29:51Z","timestamp":1543332591000},"page":"130-135","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":295,"title":["FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells"],"prefix":"10.1038","volume":"564","author":[{"given":"Xiangbo","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingdong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shutan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibing","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manman","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronggui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-cong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penghui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenqi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,28]]},"reference":[{"key":"756_CR1","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1002\/j.1460-2075.1992.tb05481.x","volume":"11","author":"Y Ishida","year":"1992","unstructured":"Ishida, Y., Agata, Y., Shibahara, K. & Honjo, T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 11, 3887\u20133895 (1992).","journal-title":"EMBO J."},{"key":"756_CR2","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nm730","volume":"8","author":"H Dong","year":"2002","unstructured":"Dong, H. et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8, 793\u2013800 (2002).","journal-title":"Nat. Med."},{"key":"756_CR3","doi-asserted-by":"publisher","first-page":"12293","DOI":"10.1073\/pnas.192461099","volume":"99","author":"Y Iwai","year":"2002","unstructured":"Iwai, Y. et al. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc. Natl Acad. Sci. USA 99, 12293\u201312297 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"756_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1126\/science.aaa8172","volume":"348","author":"P Sharma","year":"2015","unstructured":"Sharma, P. & Allison, J. P. The future of immune checkpoint therapy. Science 348, 56\u201361 (2015).","journal-title":"Science"},{"key":"756_CR5","doi-asserted-by":"publisher","first-page":"4832","DOI":"10.4049\/jimmunol.181.7.4832","volume":"181","author":"KJ Oestreich","year":"2008","unstructured":"Oestreich, K. J., Yoon, H., Ahmed, R. & Boss, J. M. NFATc1 regulates PD-1 expression upon T cell activation. J. Immunol. 181, 4832\u20134839 (2008).","journal-title":"J. Immunol."},{"key":"756_CR6","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/ni.2046","volume":"12","author":"C Kao","year":"2011","unstructured":"Kao, C. et al. Transcription factor T-bet represses expression of the inhibitory receptor PD-1 and sustains virus-specific CD8+ T cell responses during chronic infection. Nat. Immunol. 12, 663\u2013671 (2011).","journal-title":"Nat. Immunol."},{"key":"756_CR7","doi-asserted-by":"publisher","first-page":"15419","DOI":"10.1073\/pnas.1206370109","volume":"109","author":"G Xiao","year":"2012","unstructured":"Xiao, G., Deng, A., Liu, H., Ge, G. & Liu, X. Activator protein 1 suppresses antitumor T-cell function via the induction of programmed death 1. Proc. Natl Acad. Sci. USA 109, 15419\u201315424 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"756_CR8","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.immuni.2014.10.013","volume":"41","author":"MM Staron","year":"2014","unstructured":"Staron, M. M. et al. The transcription factor FoxO1 sustains expression of the inhibitory receptor PD-1 and survival of antiviral CD8+ T cells during chronic infection. Immunity 41, 802\u2013814 (2014).","journal-title":"Immunity"},{"key":"756_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/icb.2012.53","volume":"91","author":"M Mathieu","year":"2013","unstructured":"Mathieu, M., Cotta-Grand, N., Daudelin, J.-F., Th\u00e9bault, P. & Labrecque, N. Notch signaling regulates PD-1 expression during CD8+ T-cell activation. Immunol. Cell Biol. 91, 82\u201388 (2013).","journal-title":"Immunol. Cell Biol."},{"key":"756_CR10","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.immuni.2011.06.015","volume":"35","author":"B Youngblood","year":"2011","unstructured":"Youngblood, B. et al. Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8+ T cells. Immunity 35, 400\u2013412 (2011).","journal-title":"Immunity"},{"key":"756_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.immuni.2016.12.015","volume":"46","author":"TL Stephen","year":"2017","unstructured":"Stephen, T. L. et al. SATB1 expression governs epigenetic repression of PD-1 in tumor-reactive T cells. Immunity 46, 51\u201364 (2017).","journal-title":"Immunity"},{"key":"756_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature23643","volume":"549","author":"ML Burr","year":"2017","unstructured":"Burr, M. L. et al. CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity. Nature 549, 101\u2013105 (2017).","journal-title":"Nature"},{"key":"756_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12632","volume":"7","author":"C-W Li","year":"2016","unstructured":"Li, C.-W. et al. Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity. Nat. Commun. 7, 12632 (2016).","journal-title":"Nat. Commun."},{"key":"756_CR14","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/ni.2341","volume":"13","author":"J Zhao","year":"2012","unstructured":"Zhao, J. et al. F-box protein FBXL19-mediated ubiquitination and degradation of the receptor for IL-33 limits pulmonary inflammation. Nat. Immunol. 13, 651\u2013658 (2012).","journal-title":"Nat. Immunol."},{"key":"756_CR15","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/nrd4432","volume":"13","author":"JR Skaar","year":"2014","unstructured":"Skaar, J. R., Pagan, J. K. & Pagano, M. SCF ubiquitin ligase-targeted therapies. Nat. Rev. Drug Discov. 13, 889\u2013903 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"756_CR16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev-biochem-060310-170328","volume":"81","author":"D Komander","year":"2012","unstructured":"Komander, D. & Rape, M. The ubiquitin code. Annu. Rev. Biochem. 81, 203\u2013229 (2012).","journal-title":"Annu. Rev. Biochem."},{"key":"756_CR17","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.cell.2016.08.052","volume":"166","author":"M Singer","year":"2016","unstructured":"Singer, M. et al. A distinct gene module for dysfunction uncoupled from activation in tumor-infiltrating T cells. Cell 166, 1500\u20131511 (2016).","journal-title":"Cell"},{"key":"756_CR18","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1126\/science.1229620","volume":"338","author":"MA Paley","year":"2012","unstructured":"Paley, M. A. et al. Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection. Science 338, 1220\u20131225 (2012).","journal-title":"Science"},{"key":"756_CR19","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nature19330","volume":"537","author":"SJ Im","year":"2016","unstructured":"Im, S. J. et al. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy. Nature 537, 417\u2013421 (2016).","journal-title":"Nature"},{"key":"756_CR20","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.cell.2017.07.024","volume":"170","author":"SC Wei","year":"2017","unstructured":"Wei, S. C. et al. Distinct cellular mechanisms underlie anti-CTLA-4 and anti-PD-1 checkpoint blockade. Cell 170, 1120\u20131133 (2017).","journal-title":"Cell"},{"key":"756_CR21","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/JLB.2RI0717-278R","volume":"103","author":"S Mitra","year":"2018","unstructured":"Mitra, S. & Leonard, W. J. Biology of IL-2 and its therapeutic modulation: mechanisms and strategies. J. Leukoc. Biol. 103, 643\u2013655 (2018).","journal-title":"J. Leukoc. Biol."},{"key":"756_CR22","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","volume":"33","author":"DS Thommen","year":"2018","unstructured":"Thommen, D. S. & Schumacher, T. N. T cell dysfunction in cancer. Cancer Cell 33, 547\u2013562 (2018).","journal-title":"Cancer Cell"},{"key":"756_CR23","doi-asserted-by":"publisher","first-page":"11906","DOI":"10.1073\/pnas.1002569107","volume":"107","author":"C Krieg","year":"2010","unstructured":"Krieg, C., L\u00e9tourneau, S., Pantaleo, G. & Boyman, O. Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells. Proc. Natl Acad. Sci. USA 107, 11906\u201311911 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"756_CR24","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.ccell.2015.03.004","volume":"27","author":"EF Zhu","year":"2015","unstructured":"Zhu, E. F. et al. Synergistic innate and adaptive immune response to combination immunotherapy with anti-tumor antigen antibodies and extended serum half-life IL-2. Cancer Cell 27, 489\u2013501 (2015).","journal-title":"Cancer Cell"},{"key":"756_CR25","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.4049\/jimmunol.1490019","volume":"192","author":"SA Rosenberg","year":"2014","unstructured":"Rosenberg, S. A. IL-2: the first effective immunotherapy for human cancer. J. Immunol. 192, 5451\u20135458 (2014).","journal-title":"J. Immunol."},{"key":"756_CR26","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1172\/JCI67008","volume":"123","author":"EE West","year":"2013","unstructured":"West, E. E. et al. PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells. J. Clin. Invest. 123, 2604\u20132615 (2013).","journal-title":"J. Clin. Invest."},{"key":"756_CR27","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nature17412","volume":"531","author":"W Yang","year":"2016","unstructured":"Yang, W. et al. Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism. Nature 531, 651\u2013655 (2016).","journal-title":"Nature"},{"key":"756_CR28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/nature12988","volume":"506","author":"P Zhou","year":"2014","unstructured":"Zhou, P. et al. In vivo discovery of immunotherapy targets in the tumour microenvironment. Nature 506, 52\u201357 (2014).","journal-title":"Nature"},{"key":"756_CR29","doi-asserted-by":"publisher","first-page":"E3246","DOI":"10.1073\/pnas.1421463112","volume":"112","author":"Y Gao","year":"2015","unstructured":"Gao, Y. et al. Inflammation negatively regulates FOXP3 and regulatory T-cell function via DBC1. Proc. Natl Acad. Sci. USA 112, E3246\u2013E3254 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"756_CR30","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/ni.1995","volume":"12","author":"XP Yang","year":"2011","unstructured":"Yang, X. P. et al. Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5. Nat. Immunol. 12, 247\u2013254 (2011).","journal-title":"Nat. Immunol."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41586-018-0756-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41586-018-0756-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41586-018-0756-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:51:28Z","timestamp":1684619488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-018-0756-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,28]]},"references-count":30,"journal-issue":{"issue":"7734","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["756"],"URL":"https:\/\/doi.org\/10.1038\/s41586-018-0756-0","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,28]]},"assertion":[{"value":"16 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}